- Specific gut bacteria linked to increased cardiovascular risk in breast cancer patients undergoing chemotherapy.
- Higher relative abundance of Bacteroidaceae family bacteria correlated with elevated cardiac risk indicators.
- Potential implications for personalized probiotic interventions to mitigate treatment-induced cardiotoxicity.
- Study recruited 98 women over age 60 from three European cancer treatment centers.
- Findings suggest a possible role of the microbiome in patients' heart health during chemotherapy.
- The study is part of the larger EU Horizon 2020-funded CARDIOCARE project.
- Future research aims to expand to 600 women to validate early findings and explore probiotic interventions.
- Research presented at the European Cardio-Oncology 2025 congress in Florence, Italy.
Gut Bacteria Predict Chemotherapy-Related Heart Damage
Conexiant
June 20, 2025
